Analystreport

Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview